Point72 Hong Kong LTD Corbus Pharmaceuticals Holdings, Inc. Transaction History

Point72 Hong Kong LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.39 - $2.21 $2,565 - $4,079	-1,846 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$1.27 - $3.42 $2,344 - $6,313	1,846 New	1,846 $4,000
Q4 2020 Feb 16, 2021	SELL	$0.94 - $1.89 $568 - $1,143	-605 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.5 - $9.38 $1,461 - $9,136	-974 Reduced 61.68%	605 $1,000
Q2 2020 Aug 14, 2020	BUY	$4.79 - $8.39 $7,563 - $13,247	1,579 New	1,579 $13,000

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $2.08B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.